Mystery cannabis 'consortium' eyeing Longmont's biggest biz property

Warning message

The subscription service is currently unavailable. Please try again later.

Sprawling 70-acre campus is listed for $85M

Pharmaceutical interests with ties to cannabis are reported to be involved in talks to purchase Longmont’s largest commercial property: The 70-acre facility formerly home to European biotech firm Amgen.

The campus was put up for sale in June for an asking price of $85 million, following the listing of Amgen’s 300,000-square-foot Boulder facility. That property was purchased for $14.6 million by AstraZeneca in September.

Greenwood Village-based Binswanger was tapped to list both properties. The real estate organization did not broker the AstraZeneca deal, senior vice president Eric Dienstbach told the Denver Post in September, but is currently marketing the Longmont property.

Dienstbach confirmed this week that at least two interested parties are involved in negotiations for the property — including one with ties to cannabis.

One interested party is “a consortium of doctors, scientists and pharmaceutical products — let’s...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.